Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2A | P14555 | 6/20 | 0.58 |
| ▸ | PLA2G5 | P39877 | 3/20 | 0.58 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.52 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.47 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.47 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.44 |
| ▸ | PPARG | P37231 | 3/20 | 0.43 |
| ▸ | PPARD | Q03181 | 3/20 | 0.43 |
| ▸ | PPARA | Q07869 | 3/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.43 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.43 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.43 |
| ▸ | TLR2 | O60603 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | ESR1 | P03372 | 1/20 | 0.43 |
| ▸ | FABP4 | P15090 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2773206 | 1.00 | PLA2G2A (0.58) | PLA2G2APLA2G5PLA2G4ANOD1PLA2G2C | |
| SCHEMBL2773637 | 1.00 | PLA2G2A (0.58) | PLA2G2APLA2G5PLA2G4ANOD1PLA2G2C | |
| SCHEMBL2771859 | 0.90 | PLA2G2A (0.62) | PLA2G2APLA2G5PLA2G4AALDH1A1MEN1 | |
| SCHEMBL2771857 | 0.90 | PLA2G2A (0.62) | PLA2G2APLA2G5PLA2G4AALDH1A1MEN1 | |
| SCHEMBL2770844 | 0.88 | PLA2G2A (0.68) | PLA2G2APLA2G5PLA2G4ANOD1PLA2G2C | |
| SCHEMBL2770848 | 0.88 | PLA2G2A (0.68) | PLA2G2APLA2G5PLA2G4ANOD1PLA2G2C | |
| SCHEMBL13286584 | 0.84 | FOLH1 (0.44) | — | |
| SCHEMBL13286593 | 0.84 | FOLH1 (0.44) | — | |
| SCHEMBL2117116 | 0.83 | PLA2G2A (0.63) | PLA2G2APLA2G5PLA2G4ANOD1PLA2G2C | |
| SCHEMBL2117121 | 0.83 | PLA2G2A (0.63) | PLA2G2APLA2G5PLA2G4ANOD1PLA2G2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7745489-B2 | Compositions and methods for inhibition of phospholipase A2 mediated inflammation | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2010-06-29 | — | — | US | disclosed |
| EP-1490328-A4 | COMPOSITIONS AND METHODS FOR INHIBITION OF PHOSPHOLIPASE A2 MEDIATED INFLAMMATION | UNIV CALIFORNIA (US) | 2007-08-15 | — | — | EP | disclosed |
| US-20050148549-A1 | Compositions and methods for inhibition of phospholipase a2 mediated inflammation | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2005-07-07 | — | — | US | disclosed |
| EP-1490328-A1 | COMPOSITIONS AND METHODS FOR INHIBITION OF PHOSPHOLIPASE A2 MEDIATED INFLAMMATION | The Regents of The University of California (US) | 2004-12-29 | — | — | EP | disclosed |
| WO-2003076389-A1 | COMPOSITIONS AND METHODS FOR INHIBITION OF PHOSPHOLIPASE A2 MEDIATED INFLAMMATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2003-09-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050148549-A1 | Compositions and methods for inhibition of phospholipase a2 mediated inflammation | PLA2G4A, PLA2G4B, PLA2G1B | PLA2G2A 5/4885PLA2G5 8/4885PLA2G4A 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.